Clinical Trials Browser

Phase 1/2 × Tiragolumab × Tumor-Agnostic × Clear all

NCT05394337 2025-10-09

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

Phase 1/2 Recruiting

Neoplasms